Dupilumab in Inflammatory Skin Diseases: A Systematic Review. | 2023 | Biomolecules |
Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors. | 2022 | Journal of the European Academy of Dermatology and Venereology |
Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison. | 2022 | Journal of Medical Economics |
Comparative efficacy and safety of tezepelumab and other biologics in patients with inadequately controlled asthma according to thresholds of type 2 inflammatory biomarkers: a systematic review and network meta-analysis. | 2022 | Cells |
Facial and neck erythema associated with dupilumab treatment: a systematic review. | 2021 | Journal of the American Academy of Dermatology |
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI biologicals guidelines. | 2021 | Allergy |
Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. | 2021 | Allergy |
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. | 2021 | Allergy |
Biological therapies for atopic dermatitis: a systematic review. | 2021 | Dermatology |
Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis. | 2021 | Journal of the European Academy of Dermatology and Venereology |
Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis. | 2021 | JAMA Dermatology |
Clinical and pharmacoeconomic combined report: dupilumab (Duxipent) for type 2 or eosinophilic asthma. | 2021 | CADTH |
Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma. | 2021 | Cochrane Database of Systematic Review |
Effects of systemic therapies on pruritus in adults with atopic dermatitis: a systematic review and meta-analysis. | 2021 | Clinical and Experimental Dermatology |
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. | 2021 | Rhinitis, Sinusitis, and Ocular Allergy |
Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis. | 2021 | Rhinitis, Sinusitis, and Ocular Allergy |
Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis. | 2021 | Journal of the European Academy of Dermatology and Venereology |
Comparing quality of life outcomes of JAK inhibitors and biological treatments for atopic dermatitis: a systematic review and network meta-analysis. | 2021 | Expert Review of Clinical Pharmacology |
Comparative efficacy and safety of dupilumab and benralizumab in patients with inadequately controlled asthma: a systematic review. | 2020 | International Journal of Molecular Sciences |
The role of biologics in chronic rhinosinusitis: a systematic review. | 2020 | International Forum of Allergy and Rhinology |
Clinical review report: dupilumab (Dupixent) for patients aged 12 years and older with moderate-to-severe atopic dermatitis. | 2020 | CADTH |
Biologics for chronic rhinosinusitis. | 2020 | The Cochrane Database of Systematic Reviews |
Systemic treatments for eczema: a network meta‐analysis. | 2020 | The Cochrane Database of Systematic Reviews |
Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. | 2020 | Current Medical Research and Opinion |
Use of dupilumab on the treatment of moderate-to-severe asthma: a systematic review. | 2019 | Revista da Associação Médica Brasileira |
Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis. | 2019 | Respiratory Research |
Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials. | 2019 | The Journal of Asthma |
Are biologics efficacious in atopic dermatitis? A systematic review and meta-analysis. | 2018 | American Journal of Clinical Dermatology |
Clinical review report: dupilumab (Dupixent) for adult patients with moderate-to-severe atopic dermatitis. | 2018 | CADTH |
Dupilumab treatment in moderate-to-severe atopic dermatitis: a systematic review and meta-analysis. | 2018 | Journal of Dermatological Science |